James V. Lacey, Jr., Ph.D., M.P.H.
- Expansion of the California Teachers Study
- Risk factors of gynecologic cancers
- Post menopausal hormone use and cancer risk
- Epidemiologic cohort studies
Dr. Lacey is the director of the Division of Cancer Etiology at Beckman Research Institute of City of Hope and serves as Principal Investigator for the New Biospecimens to Enhance Research in the California Teachers Study project.
Lacey’s work has been key in demonstrating that women using menopausal progestins and estrogens are more likely to develop uterine and ovarian cancer. He is continuing to investigate how hormones affect the risk of developing uterine cancer, ovarian cancer, breast cancer and other diseases among women.
Dr. Lacey received his Ph.D. from the Horace H. Rackham School of Graduate Studies of the University of Michigan. After completing a postdoctoral fellowship at the National Cancer Institute (NCI), Dr. Lacey was an Investigator in the NCI’s Division of Cancer Epidemiology and Genetics from 2001 to 2009. He joined the faculty at City of Hope in 2009; his primary research interest is the epidemiology of breast, uterine, and ovarian cancers.
- 2009 - present, Associate Professor, Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA
- 2001 - 2009, Investigator (Tenure-Track), Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI), National Institutes of Health (NIH), Rockville, MD
- 1998 - 2001, Cancer Research Training Award (Postdoctoral Fellow), Division of Cancer Epidemiology and Genetics, NCI, NIH, Rockville, MD
- Cancer Etiology
- Population Sciences
- 1998, University of Michigan, Horace H. Rackham School of Graduate Studies, Ann Arbor, MI, Ph.D., Epidemiologic Science
- 1995, University of Michigan, School of Public Health, Ann Arbor, MI, M.P.H., Epidemiology
- 1993, University of Michigan, College of Literature, Science, and the Arts, Ann Arbor, MI, B.S., Psychology as a Natural Science
March 08, 2017
March 06, 2017
February 27, 2017
March 18, 2015
February 02, 2015
Information listed here is obtained from Pubmed, a public database; City of Hope is not responsible for its accuracy.
- 2009 - present, Editorial Board, Cancer Epidemiology, Biomarkers and Prevention
- 2006 - present, E2C2 (Epidemiology of Endometrial Cancer Consortium) Steering Committee
- 2004 - 2009, Breast and Gynecological Malignancies Faculty Steering Committee, NCI
- 2003 - present, American College of Epidemiology (Member)
- 2002 - 2009, NIH Intramural Program on Research on Women's Health Steering Committee
- 2001 - present, Molecular Epidemiology Group, American Association for Cancer Research (AACR)
- 1999 - present, AACR
- 2018, NIH/NCI Board of Scientific Advisors
- 2018, Salesforce Healthcare Research Trailblazer Award
- 2018, Bensenson Distinguished Lecturer, SDSU Graduate School of Public Health
- 2005, DCEG Intramural Research Award, Bethesda, MD
- 2005, NIH Award of Merit, Bethesda, MD
- 2001, Fellows Award for Research Excellence, NCI, NIH, Bethesda, MD
- 2000, Division of Cancer Epidemiology & Genetics (DCEG), Fellowship Achievement Award, NCI, NIH, Bethesda, MD